Improved AAV tropism is essential for gene therapy to reach its full potential. New capsid engineering techniques are taking on this challenge. Clinical translation of gene therapies has a history ...
Underpinning Voyager’s mission is its trademark AAV capsid-discovery platform, Tropism Redirection of AAV by Cell-type-specific Expression of RNA (TRACER). This broadly applicable, functional ...
According to Carter, the company is seeking to overcome these challenges through their TRACER™ (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) capsid discovery platform.
Researchers prefer AAV vectors due to their broad tissue tropism, high safety profile, and adaptability in manufacturing procedures. In the present review, researchers explored AAV-vectored ...
The Company is advancing an innovative therapeutics pipeline based on novel AAV capsid variants with unprecedented potency, specificity, and tropism. Latus was founded by technology from Professor ...
The Company is advancing an innovative therapeutics pipeline based on novel AAV capsid variants with unprecedented potency, specificity, and tropism. Latus was founded by technology from Professor ...
Agreement allows Andelyn to use Stanton Lab CNS capsids to perform R&D services for clients developing gene therapies.